{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T04:07:55Z","timestamp":1763179675106,"version":"3.45.0"},"reference-count":44,"publisher":"Wiley","issue":"21","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Laboratory Analysis"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>With an increasing number of unmet medical needs for autoimmune diseases (AD) in the United States, it is important to assess the value of laboratory assays in diagnosis. Healthcare providers must understand general and specific laboratory results that can lead to an efficient diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A nonexperimental study using a retrospective design and data collected between 2018 and 2021 was completed to explore whether the presence of positive anti\u2010ENA and anti\u2010dsDNA antibodies in individuals with an autoimmune disorder (anti\u2010ENA,\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091495; anti\u2010dsDNA,\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091261) can be predicted by their demographics and selected general laboratory test results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      For predicting anti\u2010ENA, multiple logistic regression analysis\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      (1) =\u2009237.62,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 indicated antinuclear antibody (ANA), complement C3, globulin, monocyte\u2010to\u2010lymphocyte ratio (MLR), and blood urea nitrogen (BUN) were statistically associated with the probability of a positive anti\u2010ENA result. The regression analysis had a sensitivity of 98.6% and a specificity measure of 16.1%. Regarding anti\u2010dsDNA, multiple logistic regression analysis\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      (1)\u2009=\u2009388.04,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001, indicated that complement C3, complement C4, pH, urine protein, and neutrophil\u2010to\u2010lymphocyte ratio (NLR) were statistically associated with the probability of a positive anti\u2010dsDNA result. The regression analysis had a sensitivity of 77.7% and a specificity measure of 64.5%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In diagnosing an AD, ANA, complement C3, globulin, MLR, and BUN are important factors in patients with a positive anti\u2010ENA. In determining Systemic Lupus Erythematosus diagnosis, complement C3, complement C4, pH, urine protein, and NLR are important factors in patients with a positive anti\u2010dsDNA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jcla.70106","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:39:58Z","timestamp":1761284398000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive Value of Laboratory Assays Toward Autoimmune Diseases"],"prefix":"10.1002","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7079-9950","authenticated-orcid":false,"given":"Kellen J.","family":"Begeman","sequence":"first","affiliation":[{"name":"University of Indianapolis  Indianapolis Indiana USA"},{"name":"University of Indianapolis, Indianapolis, INLabcorp, Burlington, NC  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"White","sequence":"additional","affiliation":[{"name":"University of Indianapolis, Indianapolis, INLabcorp, Burlington, NC  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth S.","family":"Moore","sequence":"additional","affiliation":[{"name":"University of Indianapolis  Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi H.","family":"Ewen","sequence":"additional","affiliation":[{"name":"University of Indianapolis  Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_13_2_1","DOI":"10.1186\/s13317-020-00133-1"},{"doi-asserted-by":"publisher","key":"e_1_2_13_3_1","DOI":"10.5662\/wjm.v7.i1.1"},{"doi-asserted-by":"publisher","key":"e_1_2_13_4_1","DOI":"10.1172\/JCI78088"},{"doi-asserted-by":"publisher","key":"e_1_2_13_5_1","DOI":"10.1097\/01.NUMA.0000455740.32485.9c"},{"doi-asserted-by":"publisher","key":"e_1_2_13_6_1","DOI":"10.1016\/j.cll.2019.07.005"},{"doi-asserted-by":"publisher","key":"e_1_2_13_7_1","DOI":"10.1016\/j.jaci.2009.09.041"},{"doi-asserted-by":"publisher","key":"e_1_2_13_8_1","DOI":"10.3389\/fimmu.2020.00001"},{"key":"e_1_2_13_9_1","first-page":"625","article-title":"Clinical Diagnostic Performance of Different Methods for the Detection of Antibodies to Extractable Nuclear Antigens in Connective Tissue Diseases: A Cohort Study","volume":"57","author":"Lora P. S.","year":"2011","journal-title":"Clinical Laboratory"},{"doi-asserted-by":"publisher","key":"e_1_2_13_10_1","DOI":"10.1016\/j.autrev.2008.06.005"},{"doi-asserted-by":"publisher","key":"e_1_2_13_11_1","DOI":"10.1128\/cdli.9.1.1\u20107.2002"},{"doi-asserted-by":"publisher","key":"e_1_2_13_12_1","DOI":"10.1111\/1756\u2010185X.14245"},{"doi-asserted-by":"publisher","key":"e_1_2_13_13_1","DOI":"10.1002\/art.1780370214"},{"doi-asserted-by":"publisher","key":"e_1_2_13_14_1","DOI":"10.3349\/ymj.2020.61.1.73"},{"doi-asserted-by":"publisher","key":"e_1_2_13_15_1","DOI":"10.1371\/journal.pone.0278441"},{"doi-asserted-by":"publisher","key":"e_1_2_13_16_1","DOI":"10.1136\/annrheumdis-2018-213543"},{"doi-asserted-by":"publisher","key":"e_1_2_13_17_1","DOI":"10.1136\/annrheumdis-2018-213516"},{"doi-asserted-by":"publisher","key":"e_1_2_13_18_1","DOI":"10.1002\/art.41214"},{"doi-asserted-by":"publisher","key":"e_1_2_13_19_1","DOI":"10.1016\/j.jtauto.2022.100145"},{"doi-asserted-by":"publisher","key":"e_1_2_13_20_1","DOI":"10.1007\/s10067-004-0937-0"},{"doi-asserted-by":"publisher","key":"e_1_2_13_21_1","DOI":"10.3389\/fimmu.2019.00672"},{"doi-asserted-by":"publisher","key":"e_1_2_13_22_1","DOI":"10.3389\/fimmu.2018.01057"},{"doi-asserted-by":"publisher","key":"e_1_2_13_23_1","DOI":"10.3390\/cells10010148"},{"doi-asserted-by":"publisher","key":"e_1_2_13_24_1","DOI":"10.5152\/eurjrheum.2020.19132"},{"key":"e_1_2_13_25_1","first-page":"609","article-title":"Elevated Serum Globulin Fraction as a Biomarker of Multiyear Disease Severity in Inflammatory Bowel Disease","volume":"35","author":"Hashash J. G.","year":"2022","journal-title":"Annals of Gastroenterology"},{"doi-asserted-by":"publisher","key":"e_1_2_13_26_1","DOI":"10.2147\/JIR.S347161"},{"doi-asserted-by":"publisher","key":"e_1_2_13_27_1","DOI":"10.2147\/JIR.S335671"},{"doi-asserted-by":"publisher","key":"e_1_2_13_28_1","DOI":"10.1007\/s00296-020-04529-0"},{"doi-asserted-by":"publisher","key":"e_1_2_13_29_1","DOI":"10.12659\/MSM.912495"},{"doi-asserted-by":"publisher","key":"e_1_2_13_30_1","DOI":"10.1111\/apm.12722"},{"doi-asserted-by":"publisher","key":"e_1_2_13_31_1","DOI":"10.3389\/fimmu.2019.01140"},{"doi-asserted-by":"publisher","key":"e_1_2_13_32_1","DOI":"10.1186\/ar1208"},{"doi-asserted-by":"publisher","key":"e_1_2_13_33_1","DOI":"10.1007\/s12016-017-8608-5"},{"doi-asserted-by":"publisher","key":"e_1_2_13_34_1","DOI":"10.1172\/JCI136254"},{"key":"e_1_2_13_35_1","first-page":"1","article-title":"Systemic Lupus Erythematosus With and Without Anti\u2010dsDNA Antibodies: Analysis From a Large Monocentric Cohort","volume":"2015","author":"Conti F.","year":"2015","journal-title":"Mediators of Inflammation"},{"doi-asserted-by":"publisher","key":"e_1_2_13_36_1","DOI":"10.3390\/ijms22137143"},{"key":"e_1_2_13_37_1","first-page":"1390","article-title":"Value of Combined Detection of Anti\u2010Nuclear Antibody, Anti\u2010Double\u2010Stranded DNA Antibody and C3, C4 Complements in the Clinical Diagnosis of Systemic Lupus Erythematosus","volume":"17","author":"Qu C.","year":"2019","journal-title":"Experimental and Therapeutic Medicine"},{"key":"e_1_2_13_38_1","first-page":"118","article-title":"Laboratory Studies in Autoimmune Diseases","volume":"113","author":"Moore T. L.","year":"2016","journal-title":"Missouri Medicine"},{"key":"e_1_2_13_39_1","first-page":"1","article-title":"Distal Renal Tubular Acidosis Associated With Autoimmune Diseases: Reports of 3 Cases and Review of Mechanisms","volume":"23","author":"Silveira M. A. D.","year":"2022","journal-title":"American Journal of Case Reports"},{"key":"e_1_2_13_40_1","first-page":"1","article-title":"Distal Renal Tubular Acidosis in Patients With Autoimmune Diseases\u2014An Update on Pathogenesis, Clinical Presentation and Therapeutic Strategies","volume":"10","author":"Ungureanu O.","year":"2022","journal-title":"Biomedicine"},{"doi-asserted-by":"publisher","key":"e_1_2_13_41_1","DOI":"10.1016\/j.ekir.2020.09.007"},{"doi-asserted-by":"publisher","key":"e_1_2_13_42_1","DOI":"10.1177\/0961203320983458"},{"key":"e_1_2_13_43_1","first-page":"474","article-title":"Neutrophil\u2010To\u2010Lymphocyte Ratio, Past, Present and Future Perspectives","volume":"122","author":"Zahorec R.","year":"2021","journal-title":"Bratislavsk\u00e9 Lek\u00e1rske Listy"},{"doi-asserted-by":"publisher","key":"e_1_2_13_44_1","DOI":"10.7754\/Clin.Lab.2014.140927"},{"doi-asserted-by":"publisher","key":"e_1_2_13_45_1","DOI":"10.1136\/lupus-2020-000382"}],"container-title":["Journal of Clinical Laboratory Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.70106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:59:54Z","timestamp":1763179194000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.70106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":44,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1002\/jcla.70106"],"URL":"https:\/\/doi.org\/10.1002\/jcla.70106","archive":["Portico"],"relation":{},"ISSN":["0887-8013","1098-2825"],"issn-type":[{"type":"print","value":"0887-8013"},{"type":"electronic","value":"1098-2825"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"2024-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70106"}}